Transplantation of genetically engineered cardiac fibroblasts producing recombinant human erythropoietin to repair the infarcted myocardium

BACKGROUND: Erythropoietin possesses cellular protection properties. The aim of the present study was to test the hypothesis that in situ expression of recombinant human erythropoietin (rhEPO) would improve tissue repair in rat after myocardial infarction (MI). METHODS AND RESULTS: RhEPO-producing c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruvinov, Emil, Sharabani-Yosef, Orna, Nagler, Arnon, Einbinder, Tom, Feinberg, Micha S, Holbova, Radka, Douvdevani, Amos, Leor, Jonathan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2585557/
https://www.ncbi.nlm.nih.gov/pubmed/19014419
http://dx.doi.org/10.1186/1755-1536-1-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2585557/
https://www.ncbi.nlm.nih.gov/pubmed/19014419
http://dx.doi.org/10.1186/1755-1536-1-7

Ejemplares similares